• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (21)
    • Educating APRN Students About Telehealth Credentialing, Licensing, and Billing.
    • Chemistry, Inorganic
    • Helium
    • The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial.
    • GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.
    • See All 21 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.

GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron. 2013 Apr 24; 78(2):256-68.

View in: PubMed

subject areas
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease
  • Amyloid beta-Peptides
  • Apolipoproteins E
  • Case-Control Studies
  • Chromosomes, Human, Pair 3
  • Chromosomes, Human, Pair 6
  • DNA-Binding Proteins
  • Female
  • Genome-Wide Association Study
  • Genotype
  • Humans
  • Male
  • Membrane Glycoproteins
  • Middle Aged
  • Muscle Proteins
  • Peptide Fragments
  • Phenotype
  • Phosphorylation
  • Polymorphism, Single Nucleotide
  • Receptors, Immunologic
  • Repressor Proteins
  • Risk Factors
  • Serine
  • tau Proteins
  • Trans-Activators
  • Transcription Factors

authors with profiles
  • Steven L. Carroll